July 2026– date –
-
Allogeneic CAR-T Manufacturing: Unlocking Rapid, Off-the-Shelf Cancer Therapy
Liv Hospital Turkey Overview Allogeneic CAR-T cell manufacturing is poised to revolutionize cancer treatment by providing 'off-the-shelf' solutions derived from healthy donor cells. This approach dramatically shortens treatment timelines... -
Precision Fermentation Emerges as Transformative Food Production Technology, Enabling Scalable and Cost-Effective Alternative Ingredient Supply
KLBD Kosher Certification UK Overview Precision fermentation is rapidly gaining recognition as an innovative technology in food production, enabling the scalable and cost-effective manufacturing of diverse ingredients, including those ch... -
Thermo Fisher Scientific Unveils Semi-Automated, Closed-Loop Workflow for Autologous CAR T Cell Manufacturing: A Leap in Consistency and Safety
Thermo Fisher Scientific USA Overview Thermo Fisher Scientific has introduced a new digitally compatible, semi-automated, closed, and GMP-compliant workflow platform designed to streamline autologous CAR T cell manufacturing. Integrating... -
Beckman Coulter Showcases BioLector XT Micro Bioreactor and Biomek i5 Automated Liquid Handler to Accelerate Precision Fermentation and Alternative Protein Research
Beckman Coulter Life Sciences (YouTube) USA Overview Chris Saenz of Beckman Coulter Life Sciences introduced key technologies accelerating early-stage microbiology engineering for precision fermentation and alternative proteins. The BioL... -
Methodist Healthcare Expands CAR T-Cell Therapy Trials Beyond Cancer to Autoimmune Diseases like Lupus and MS, Including Pediatric Patients
San Antonio Report USA Overview Methodist Healthcare is expanding CAR T-cell therapy clinical trials beyond oncology, actively researching applications for autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and Multiple Scler... -
ProBio Opens $25 Million Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, Creating Over 100 Highly Skilled Jobs
New Jersey Business Magazine USA Overview ProBio has inaugurated a $25 million, 128,000-square-foot Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, significantly bolstering its production capabilities for cell an... -
Precision Fermentation Powers All G’s Industrial-Scale Launch of Animal-Free Lactoferrin ‘LFX Apoprotein’ in US Market
AgFunderNews Australia Overview Australian biotechnology firm All G has commercially launched LFX Apoprotein, a novel animal-free, low-iron lactoferrin produced via precision fermentation, in the U.S. market. Currently scaled at a 60,000... -
FDA Approves Orca Bio’s Precision-Engineered Cell Therapy Tregzi (Orca-T) for Allogeneic Transplant in Adults with Hematological Malignancies
CliniExpert USA Overview The U.S. FDA has approved Orca Bio’s precision-engineered cell therapy, Tregzi™ (Orca-T®), for allogeneic transplant in adult patients with hematological malignancies. Tregzi is a personalized therapy manufacture... -
Atrium Therapeutics Receives FDA IND Clearance for RNA Therapeutic ATR 1072 to Treat PRKAG2 Syndrome, Advancing to Phase 1/2 Corventis Trial
Clival Database USA Overview Atrium Therapeutics announced FDA Investigational New Drug (IND) clearance for ATR 1072, an RNA therapeutic in development for the rare PRKAG2 syndrome. This clearance allows the company to proceed with the P... -
Aurion Biotech Unlocks Keys to Scaling Living Cell Therapies Through Commercialization of Allogeneic Corneal Endothelial Cell Therapy in Japan
Drug Discovery News USA Overview Aurion Biotech CEO Arnaud Lacoste shared critical lessons from the successful commercialization of their allogeneic corneal endothelial cell therapy in Japan, highlighting the need for robust manufacturin...
